Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$753,150
-$120,615 QoQ
Shares Held
31,277
+0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,490
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLAND CAPITAL MANAGEMENT, LLC holds $74,462,523 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
233,452 | $29,998,582 | |
| 2 | JNJ |
Johnson & Johnson
|
62,572 | $15,891,410 | |
| 3 | LLY |
ELI LILLY & Co
|
10,931 | $13,110,970 | |
| 4 | ABBV |
AbbVie Inc.
|
43,576 | $10,965,464 | |
| 5 | NVS |
Novartis AG
|
13,845 | $2,169,788 | |
| 6 | GSK |
GSK plc
|
16,642 | $872,373 | |
| 7 | PFE |
Pfizer Inc
This page
|
31,277 | $753,150 | |
| 8 | NVO |
Novo Nordisk A S
|
14,618 | $700,786 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $753,150 | 31,277 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $873,765 | 31,117 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,032,528 | 41,467 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,168,410 | 45,856 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,150,697 | 47,471 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,258,789 | 49,676 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,338,597 | 50,456 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,561,081 | 53,942 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,517,663 | 54,241 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,616,992 | 58,270 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,860,179 | 64,612 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,321,269 | 69,981 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,740,986 | 74,727 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,218,181 | 78,877 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,075,168 | 79,531 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,484,039 | 79,617 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,295,380 | 81,926 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $4,256,167 | 82,213 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $5,098,140 | 86,336 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $3,741,482 | 86,991 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $3,204,697 | 81,836 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $3,437,973 | 94,893 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $9,985,927 | 271,283 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $10,728,573 | 292,332 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $9,691,178 | 296,366 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $9,348,768 | 286,421 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||